Hair Loss From Beta Blockers: Which Ones and Why

What Is Beta Blocker–Induced Hair Loss?

Beta blocker–induced hair loss is a form of medication-related hair shedding that occurs in some people who take beta-adrenergic blocking agents. These drugs are commonly prescribed for high blood pressure, heart conditions, anxiety, and migraines. While hair loss is not the most common side effect, it is recognised in clinical literature and can be distressing for those affected. The shedding is typically diffuse—meaning it happens across the scalp rather than in a single patch—and it often starts weeks to months after beginning the medication or increasing the dose. It is important to note that not everyone who takes beta blockers will experience hair loss, and the exact frequency varies between different drugs in this class.

How Beta Blockers Can Cause Hair Loss: The Mechanisms

The precise way beta blockers trigger hair loss is not fully understood, but several mechanisms have been proposed. Beta blockers work by blocking the effects of adrenaline and noradrenaline on beta receptors throughout the body. These receptors are also present in the skin and hair follicles, and altering their activity may disrupt normal hair growth cycles. Additionally, some beta blockers can affect blood flow to the skin, including the scalp, which may reduce nutrient delivery to hair follicles. Another possibility is that the drug interferes with the hair growth cycle directly, pushing more hairs into the resting (telogen) phase and causing them to shed prematurely—a condition known as telogen effluvium. In some cases, an immune-mediated reaction or a drug-induced lupus-like syndrome may contribute, though this is rare.

• Reduced scalp blood flow: Beta blockers can lower blood pressure and constrict blood vessels, potentially decreasing oxygen and nutrient supply to hair follicles.
• Direct effect on hair cycle: Some drugs may disrupt the normal anagen (growth) to telogen (resting) transition, leading to increased shedding.
• Hormonal or immune interactions: Rarely, beta blockers may trigger immune responses or hormonal changes that affect hair growth.
• Individual susceptibility: Genetic factors and overall health influence who experiences hair loss as a side effect.

Which Beta Blockers Are Linked to Hair Loss?

Not all beta blockers carry the same risk. Hair loss has been reported more frequently with certain agents, particularly those that are non-selective or have specific chemical structures. The table below summarises the beta blockers most commonly associated with hair loss in medical literature and clinical reports. Keep in mind that the evidence is largely based on case reports and observational data, and the actual incidence is low for most drugs.

Symptoms and Diagnosis: Is Your Medication the Culprit?

Recognising beta blocker–induced hair loss can be tricky because hair shedding is common and can have many causes. The typical pattern is a diffuse thinning over the entire scalp, often noticed as increased hair in the shower drain or on the pillow. It usually begins within a few weeks to a few months after starting the drug or changing the dose. There is no specific test for this condition; diagnosis is largely clinical. Your doctor will take a detailed history, including medication use, and may perform a physical exam or blood tests to rule out other causes like thyroid disorders, iron deficiency, or hormonal imbalances. A dermatologist might use a dermoscope to examine the scalp or perform a hair pull test. The key is to establish a temporal relationship between the drug and the shedding, and to exclude other common causes of hair loss.

• Diffuse shedding across the scalp, not patchy
• Increased hair loss on pillow, in shower, or when brushing
• Onset weeks to months after starting or increasing the beta blocker
• No signs of scalp inflammation or scarring
• Improvement after stopping the suspected drug (if done under medical supervision)

Treatment Options for Beta Blocker–Related Hair Loss

The first step in managing beta blocker–induced hair loss is to speak with your doctor about whether the medication can be switched to a different class of blood pressure medication or a beta blocker less associated with hair loss. If the drug is essential and cannot be changed, other treatments may help. Topical minoxidil is a common first-line treatment for diffuse hair thinning and can be used alongside beta blockers. Finasteride is not typically used for medication-induced hair loss unless there is coexisting male pattern baldness, as its mechanism targets androgen-driven hair loss. Platelet-rich plasma (PRP) therapy is another option that can stimulate hair follicles and improve density. In some cases, low-level laser therapy or nutritional supplementation (if deficiencies are found) may be recommended. It's important to have realistic expectations: hair regrowth after stopping the offending drug can take several months, and treatments like minoxidil need to be used consistently to maintain benefits.

• Medication review and possible switch to an alternative beta blocker or different drug class
• Topical minoxidil to stimulate hair growth
• Finasteride only if there is concurrent androgenetic alopecia
• Platelet-rich plasma (PRP) injections to promote follicle activity
• Low-level laser therapy as an adjunct
• Addressing any nutritional deficiencies (e.g., iron, vitamin D) under medical guidance

Is a Hair Transplant Suitable for Medication-Induced Hair Loss?

A hair transplant is generally not the first line of treatment for beta blocker–induced hair loss. Because the hair loss is often diffuse and reversible once the medication is stopped or changed, surgery is usually considered only after other options have been explored and the condition has stabilised. If the shedding is purely due to the drug and the drug is discontinued, hair may regrow on its own, making a transplant unnecessary. However, if the hair loss has caused permanent thinning in specific areas (for example, if there is coexisting genetic hair loss), a transplant could be an option. It's crucial to wait until the hair loss has stabilised for at least 6–12 months before considering surgery, as transplanting into an active shedding area can lead to poor results. A reputable surgeon will assess your medical history, including medication use, and may recommend a scalp biopsy or other tests to confirm the cause. They will also discuss whether you need to switch medications before surgery to optimise healing and graft survival.

• Transplant is not typically recommended while the offending drug is still being taken and shedding is active.
• Surgery may be appropriate if hair loss has stabilised and there are permanent bald patches.
• A thorough medical evaluation is needed to rule out other causes and confirm the diagnosis.
• Waiting 6–12 months after stopping the drug (if safe to do so) allows natural regrowth to occur before deciding on surgery.
• If a transplant is performed, ongoing medical therapy (e.g., minoxidil) may be advised to support results.

What to Expect During Recovery and Beyond

If you do undergo a hair transplant for medication-induced hair loss (after stabilisation), the recovery process is similar to any other transplant. The first few days involve mild discomfort, swelling, and scabbing. Most people can return to work within a week, but this varies from person to person. The transplanted hairs typically shed within 2–4 weeks—this is normal and not a sign of failure. New growth starts around 3–4 months, with noticeable results at 6–9 months and final results at 12–18 months. It's important to continue any prescribed medical therapy (like minoxidil) to protect both transplanted and native hair. Regular follow-ups with your surgeon will monitor progress. Long-term, you'll need to manage the underlying cause—if beta blockers are still necessary, your doctor may monitor your hair closely or adjust treatment.

• First week: mild pain, swelling, and scabbing; avoid strenuous activity.
• 2–4 weeks: transplanted hairs shed (shock loss), which is normal.
• 3–4 months: new hair growth begins.
• 6–9 months: visible improvement in density.
• 12–18 months: final results; continue medical therapy as advised.

Frequently Asked Questions